Ing Investment Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Ing Investment Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $13M 18M 0.72
2025-03-31 $45M 49M 0.93
2024-12-31 $110M 100M 1.10
2024-09-30 $131M 115M 1.14
2024-06-30 $33M 26M 1.29
2024-03-31 $23M 20M 1.17
2023-09-30 $47M 42M 1.12

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)
Caterpillar (CAT)
Cisco Systems (CSCO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Wells Fargo & Company (WFC)

View all positions for Ing Investment Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Tudor Investment Corporation
Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1